TG Therapeutics, Inc. (NKB2)
Market Closed
24 Feb, 20:00
XSTU 
€
25. 73
-0.07
-0.25%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
0.03 Eps
€ 25.8
Previous Close Day Range
25.5 26.08
Year Range
22.41 39.99
Want to track NKB2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NKB2 earnings report is expected in 5 days (2 Mar 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.33 | - |
| | | 0.21 | - |
| | | 0.21 | - |
| | | 0.29 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
NKB2 Earnings Reports FAQ
What is the earnings per share (EPS) for NKB2?
The current EPS is 0.03.
What is the company's earnings growth rate?
TG Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-02, based on the NKB2's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for TG Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for NKB2 at this time, as TG Therapeutics, Inc has no recent EPS data to calculate it.
